BridgeMD
New treatment option for Developmental Dyslexia
Official title V5/MT Stimulation on Reading and Reading-related Measures in Developmental Dyslexia
ClinicalTrials.gov ID: NCT05972200
What this study is testing
- What it's testing
- The present study grounds on the absence of evidence-based treatment in individuals with developmental dyslexia (DD). At this topic, the present study will explore the potential effect of transcranial direct current stimulation (tDCS) over left hemispheric direct Lateral Geniculate Nucleus (LGN)-V5/MT pathway, cerebral areas usually disrupted in individuals with DD.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 13. Healthy volunteers may be eligible.
You may be able to join if
- Italian speakers right-handed children and adolescents with dyslexia (DSM-5, APA 2013);
- Word/nonword/text reading accuracy and/or speed at least 2 Standard Deviations below the mean for school-age;
- nv IQ ≥ 85;
- normal hearing and normal or corrected-to-normal vision.
You likely can't join if
- Having a comorbidity with other primary psychiatric/neurological diagnosis (e.g., depression, anxiety, autism, ADHD);
- Having a personal history of neurological/medical/genetic diseases;
- Having ongoing drug treatment influencing brain function;
- Having epilepsy o family history of epilepsy.
The study team makes the final eligibility decision.
Where it's taking place
- Roma, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 13 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Roma, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.